F16.24
Hallucinogen dependence with hallucinogen-induced mood disorder
Clinical Classification Guidelines
Inclusion Terms
- Other hallucinogen use disorder, moderate, with other hallucinogen induced bipolar or related disorder
- Other hallucinogen use disorder, moderate, with other hallucinogen induced depressive disorder
- Other hallucinogen use disorder, severe, with other hallucinogen-induced bipolar or related disorder
- Other hallucinogen use disorder, severe, with other hallucinogen-induced depressive disorder
- Phencyclidine use disorder, moderate, with phencyclidine induced bipolar or related disorder
- Phencyclidine use disorder, moderate, with phencyclidine induced depressive disorder
- Phencyclidine use disorder, severe, with phencyclidine induced bipolar or related disorder
- Phencyclidine use disorder, severe, with phencyclidine-induced depressive disorder
Medical Intelligence & Overview
ICD-10 code F16.24 refers to a complex condition involving dependence on hallucinogens, coupled with mood disorders induced by these substances. This condition reflects significant challenges in mental health associated with the recreational or ongoing use of hallucinogenic drugs such as LSD, psilocybin, or phencyclidine (PCP). Recognizing this diagnosis is a crucial step toward understanding the intertwined nature of substance dependence and mood disturbances, which can greatly affect daily functioning and overall well-being.
Causes & Symptoms
Clinical Causes: Repeated use of hallucinogenic drugs leading to physical and psychological dependence. Use of substances like phencyclidine (PCP) or others that have a high potential for inducing mood swings. Genetic predisposition to substance dependence and mood disorders. Environmental factors such as stress, trauma, or peer influence that encourage initial drug use. Underlying mental health issues that may predispose an individual to self-medicate with hallucinogens.
Key Symptoms: Craving or strong desire to use hallucinogens. Tolerance to the drug, requiring larger doses to achieve the same effects. Withdrawal symptoms when not using the drug, such as anxiety, agitation, or mood swings. Hallucinations or visual distortions. Mood disturbances including depressive episodes or periods of mania or bipolar-like symptoms. Impaired judgment, confusion, or paranoia. Changes in sleep patterns or appetite. Difficulty functioning socially or occupationally due to symptoms.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of this condition involves a comprehensive assessment by a healthcare professional, including coverage of medical, psychological, and substance use history. Healthcare providers may utilize standardized questionnaires and psychiatric evaluations to identify dependence on hallucinogens, along with signs of mood disturbances triggered by drug use. Laboratory tests or drug screenings can support the diagnosis by confirming recent use of hallucinogens.
Treatment Protocols: Treatment plans for hallucinogen dependence with mood disorder typically include a multimodal approach: - **Detoxification:** Supervised cessation of drug use to manage withdrawal symptoms. - **Psychotherapy:** Behavioral therapies such as cognitive-behavioral therapy (CBT) or contingency management to address dependence and mood symptoms. - **Medication:** Prescription medications might be used to stabilize mood swings, manage depression or bipolar symptoms, and reduce cravings. - **Support groups:** Peer support groups can provide ongoing emotional support and motivation. - **Monitoring and follow-up:** Regular follow-up with healthcare providers to adjust treatments, prevent relapse, and manage emerging symptoms.
Clinical Advice & FAQs
Billing Guidance
Is F16.24 a billable ICD-10 code?
Yes, F16.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.24?
Clinical documentation must specify the nature of Hallucinogen dependence with hallucinogen-induced mood disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference